MedinCell S.A. (EPA:MEDCL)
26.00
+0.10 (0.39%)
At close: Dec 5, 2025
MedinCell Employees
MedinCell had 131 employees as of March 31, 2025. The number of employees decreased by 3 or -2.24% compared to the previous year.
Employees
131
Change (1Y)
-3
Growth (1Y)
-2.24%
Revenue / Employee
€211,656
Profits / Employee
€140,748
Market Cap
860.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| Ipsen | 5,358 |
| ABIVAX Société Anonyme | 69 |
| Virbac | 6,365 |
MedinCell News
- 2 months ago - Teva : FDA Grants Expanded Approval For UZEDY To Treat Bipolar I Disorder In Adults - Nasdaq
- 2 months ago - Medincell Reports Positive Phase 3 Safety Data For Olanzapine LAI; No PDSS Observed - Nasdaq
- 10 months ago - Teva Pharmaceuticals reports completion of phase 3 trial for Olanzapine LAI in Schizophrenia - Seeking Alpha